Logo image of MS

MORGAN STANLEY (MS) Stock Fundamental Analysis

USA - NYSE:MS - US6174464486 - Common Stock

165.53 USD
+1.67 (+1.02%)
Last: 10/27/2025, 2:30:53 PM
Fundamental Rating

3

Taking everything into account, MS scores 3 out of 10 in our fundamental rating. MS was compared to 235 industry peers in the Capital Markets industry. Both the profitability and financial health of MS have multiple concerns. MS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year MS was profitable.
MS had a negative operating cash flow in the past year.
In the past 5 years MS has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: MS reported negative operating cash flow in multiple years.
MS Yearly Net Income VS EBIT VS OCF VS FCFMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B

1.2 Ratios

With a Return On Assets value of 1.04%, MS is not doing good in the industry: 65.11% of the companies in the same industry are doing better.
MS has a better Return On Equity (13.07%) than 69.79% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.34%, MS is doing worse than 65.96% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MS is significantly below the industry average of 7.62%.
The 3 year average ROIC (1.17%) for MS is below the current ROIC(1.34%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.04%
ROE 13.07%
ROIC 1.34%
ROA(3y)0.89%
ROA(5y)0.97%
ROE(3y)10.46%
ROE(5y)11.1%
ROIC(3y)1.17%
ROIC(5y)1.28%
MS Yearly ROA, ROE, ROICMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

MS has a Profit Margin (12.51%) which is in line with its industry peers.
In the last couple of years the Profit Margin of MS has declined.
MS's Operating Margin of 17.07% is on the low side compared to the rest of the industry. MS is outperformed by 61.28% of its industry peers.
MS's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 54.42%, MS is in the better half of the industry, outperforming 65.53% of the companies in the same industry.
MS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 17.07%
PM (TTM) 12.51%
GM 54.42%
OM growth 3Y-20.12%
OM growth 5Y-4.82%
PM growth 3Y-20.6%
PM growth 5Y-5.48%
GM growth 3Y-16.51%
GM growth 5Y-5.78%
MS Yearly Profit, Operating, Gross MarginsMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

0

2. Health

2.1 Basic Checks

MS has less shares outstanding than it did 1 year ago.
The number of shares outstanding for MS has been increased compared to 5 years ago.
MS has a worse debt/assets ratio than last year.
MS Yearly Shares OutstandingMS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
MS Yearly Total Debt VS Total AssetsMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B 1T

2.2 Solvency

Based on the Altman-Z score of -0.08, we must say that MS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.08, MS is doing worse than 77.45% of the companies in the same industry.
A Debt/Equity ratio of 7.45 is on the high side and indicates that MS has dependencies on debt financing.
With a Debt to Equity ratio value of 7.45, MS is not doing good in the industry: 88.09% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 7.45
Debt/FCF N/A
Altman-Z -0.08
ROIC/WACCN/A
WACCN/A
MS Yearly LT Debt VS Equity VS FCFMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B

2.3 Liquidity

A Current Ratio of 0.29 indicates that MS may have some problems paying its short term obligations.
MS has a Current ratio of 0.29. This is amonst the worse of the industry: MS underperforms 82.55% of its industry peers.
A Quick Ratio of 0.29 indicates that MS may have some problems paying its short term obligations.
MS has a Quick ratio of 0.29. This is amonst the worse of the industry: MS underperforms 82.13% of its industry peers.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.29
MS Yearly Current Assets VS Current LiabilitesMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

6

3. Growth

3.1 Past

MS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.31%, which is quite impressive.
MS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.88% yearly.
The Revenue has grown by 11.08% in the past year. This is quite good.
The Revenue has been growing by 14.79% on average over the past years. This is quite good.
EPS 1Y (TTM)45.31%
EPS 3Y-0.38%
EPS 5Y8.88%
EPS Q2Q%48.94%
Revenue 1Y (TTM)11.08%
Revenue growth 3Y20.63%
Revenue growth 5Y14.79%
Sales Q2Q%18.47%

3.2 Future

Based on estimates for the next years, MS will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.26% on average per year.
MS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.32% yearly.
EPS Next Y28.4%
EPS Next 2Y16.52%
EPS Next 3Y14.95%
EPS Next 5Y10.26%
Revenue Next Year16.49%
Revenue Next 2Y10.72%
Revenue Next 3Y9.03%
Revenue Next 5Y6.32%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MS Yearly Revenue VS EstimatesMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B 80B 100B
MS Yearly EPS VS EstimatesMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.98, which indicates a correct valuation of MS.
The rest of the industry has a similar Price/Earnings ratio as MS.
MS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.89.
MS is valuated correctly with a Price/Forward Earnings ratio of 15.36.
The rest of the industry has a similar Price/Forward Earnings ratio as MS.
MS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.99.
Industry RankSector Rank
PE 16.98
Fwd PE 15.36
MS Price Earnings VS Forward Price EarningsMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MS is valued a bit cheaper than the industry average as 72.77% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.67
MS Per share dataMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MS's earnings are expected to grow with 14.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.6
PEG (5Y)1.91
EPS Next 2Y16.52%
EPS Next 3Y14.95%

4

5. Dividend

5.1 Amount

MS has a Yearly Dividend Yield of 2.51%.
MS's Dividend Yield is comparable with the industry average which is at 8.34.
Compared to an average S&P500 Dividend Yield of 2.31, MS has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.51%

5.2 History

On average, the dividend of MS grows each year by 18.94%, which is quite nice.
MS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)18.94%
Div Incr Years0
Div Non Decr Years0
MS Yearly Dividends per shareMS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

45.08% of the earnings are spent on dividend by MS. This is a bit on the high side, but may be sustainable.
The dividend of MS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP45.08%
EPS Next 2Y16.52%
EPS Next 3Y14.95%
MS Yearly Income VS Free CF VS DividendMS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B
MS Dividend Payout.MS Dividend Payout, showing the Payout Ratio.MS Dividend Payout.PayoutRetained Earnings

MORGAN STANLEY

NYSE:MS (10/27/2025, 2:30:53 PM)

165.53

+1.67 (+1.02%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)10-15 2025-10-15/bmo
Earnings (Next)01-15 2026-01-15/bmo
Inst Owners62.51%
Inst Owner Change-0.17%
Ins Owners0.2%
Ins Owner Change-0.03%
Market Cap263.36B
Revenue(TTM)116.83B
Net Income(TTM)14.14B
Analysts73.13
Price Target151.26 (-8.62%)
Short Float %1.25%
Short Ratio2.77
Dividend
Industry RankSector Rank
Dividend Yield 2.51%
Yearly Dividend3.8
Dividend Growth(5Y)18.94%
DP45.08%
Div Incr Years0
Div Non Decr Years0
Ex-Date10-31 2025-10-31 (1)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.13%
Min EPS beat(2)5.77%
Max EPS beat(2)14.48%
EPS beat(4)4
Avg EPS beat(4)15.64%
Min EPS beat(4)5.77%
Max EPS beat(4)27.07%
EPS beat(8)7
Avg EPS beat(8)10.97%
EPS beat(12)10
Avg EPS beat(12)7.76%
EPS beat(16)13
Avg EPS beat(16)7.12%
Revenue beat(2)2
Avg Revenue beat(2)2.67%
Min Revenue beat(2)1.43%
Max Revenue beat(2)3.91%
Revenue beat(4)4
Avg Revenue beat(4)3.45%
Min Revenue beat(4)1.43%
Max Revenue beat(4)4.78%
Revenue beat(8)6
Avg Revenue beat(8)1.67%
Revenue beat(12)9
Avg Revenue beat(12)12.16%
Revenue beat(16)12
Avg Revenue beat(16)9.8%
PT rev (1m)1.82%
PT rev (3m)4.62%
EPS NQ rev (1m)2.26%
EPS NQ rev (3m)5.62%
EPS NY rev (1m)11.22%
EPS NY rev (3m)14.95%
Revenue NQ rev (1m)2.28%
Revenue NQ rev (3m)5.44%
Revenue NY rev (1m)4.34%
Revenue NY rev (3m)6.9%
Valuation
Industry RankSector Rank
PE 16.98
Fwd PE 15.36
P/S 2.33
P/FCF N/A
P/OCF N/A
P/B 2.43
P/tB 3.09
EV/EBITDA 20.67
EPS(TTM)9.75
EY5.89%
EPS(NY)10.78
Fwd EY6.51%
FCF(TTM)-13.16
FCFYN/A
OCF(TTM)-11.11
OCFYN/A
SpS71.04
BVpS68
TBVpS53.59
PEG (NY)0.6
PEG (5Y)1.91
Graham Number122.14
Profitability
Industry RankSector Rank
ROA 1.04%
ROE 13.07%
ROCE 3.03%
ROIC 1.34%
ROICexc 1.49%
ROICexgc 1.57%
OM 17.07%
PM (TTM) 12.51%
GM 54.42%
FCFM N/A
ROA(3y)0.89%
ROA(5y)0.97%
ROE(3y)10.46%
ROE(5y)11.1%
ROIC(3y)1.17%
ROIC(5y)1.28%
ROICexc(3y)1.31%
ROICexc(5y)1.45%
ROICexgc(3y)1.39%
ROICexgc(5y)1.53%
ROCE(3y)2.71%
ROCE(5y)2.95%
ROICexgc growth 3Y-7.03%
ROICexgc growth 5Y1.53%
ROICexc growth 3Y-6.98%
ROICexc growth 5Y1.26%
OM growth 3Y-20.12%
OM growth 5Y-4.82%
PM growth 3Y-20.6%
PM growth 5Y-5.48%
GM growth 3Y-16.51%
GM growth 5Y-5.78%
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 7.45
Debt/FCF N/A
Debt/EBITDA 33.05
Cap/Depr 64.3%
Cap/Sales 2.89%
Interest Coverage 0.4
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.29
Altman-Z -0.08
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)74.75%
Cap/Depr(5y)63.46%
Cap/Sales(3y)3.81%
Cap/Sales(5y)3.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.31%
EPS 3Y-0.38%
EPS 5Y8.88%
EPS Q2Q%48.94%
EPS Next Y28.4%
EPS Next 2Y16.52%
EPS Next 3Y14.95%
EPS Next 5Y10.26%
Revenue 1Y (TTM)11.08%
Revenue growth 3Y20.63%
Revenue growth 5Y14.79%
Sales Q2Q%18.47%
Revenue Next Year16.49%
Revenue Next 2Y10.72%
Revenue Next 3Y9.03%
Revenue Next 5Y6.32%
EBIT growth 1Y35.01%
EBIT growth 3Y-3.64%
EBIT growth 5Y9.26%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.99%
OCF growth 3Y-65.77%
OCF growth 5Y-49.33%

MORGAN STANLEY / MS FAQ

Can you provide the ChartMill fundamental rating for MORGAN STANLEY?

ChartMill assigns a fundamental rating of 3 / 10 to MS.


What is the valuation status for MS stock?

ChartMill assigns a valuation rating of 4 / 10 to MORGAN STANLEY (MS). This can be considered as Fairly Valued.


What is the profitability of MS stock?

MORGAN STANLEY (MS) has a profitability rating of 3 / 10.


Can you provide the financial health for MS stock?

The financial health rating of MORGAN STANLEY (MS) is 0 / 10.


Can you provide the dividend sustainability for MS stock?

The dividend rating of MORGAN STANLEY (MS) is 4 / 10 and the dividend payout ratio is 45.08%.